The three classical mechanisms for protein folding - PowerPoint PPT Presentation

1 / 31
About This Presentation
Title:

The three classical mechanisms for protein folding

Description:

Title: PowerPoint Presentation Author: Prof. Dr. Bernd Bukau Last modified by: Bernd Bukau Created Date: 11/13/2002 3:37:19 PM Document presentation format – PowerPoint PPT presentation

Number of Views:250
Avg rating:3.0/5.0
Slides: 32
Provided by: ProfDrBe6
Category:

less

Transcript and Presenter's Notes

Title: The three classical mechanisms for protein folding


1
The three classical mechanisms for protein folding
(hierarchial)
(Fersht and Daggett, Cell 108, 573-582, 2002)
2
Energy landscape of protein folding
rugged landscape multi-state folding
idealized funnel landscape
As the chain forms increasing numbers of
intrachain contacts, and lowers its
internal free energy, its conformational freedom
is also reduced
A rugged landscape with kinetic traps, energy
barriers, and some narrow throughway paths to
native. Folding can be multistate
(K. Dill)
3
The folding energy landscape of a protein
4
Macromolecular crowding
(approx. 300 mg/ml)
Goodsell 1991, TiBS(16) 203-206
5
Major chaperones and their interactions with
substrates
?
6
The GroEL-GroES chaperone machine
GroEL proteins (subunits)
GroEL complex (double ring with 7 GroEL/ring)
Active complex
ATP
GroES proteins (subunits)
GroES complex (single ring with 7 GroES/ring)
7
Protein folding by GroEL and GroES
GroELGroES with enclosed polypeptide
GroEL with unfolded polypeptide
GroEL
?t 15 sec
The folding activity is ATP-dependent!
U. Hartl
8
(No Transcript)
9
Conformational changes induced by nucleotide and
GroES (model based on cryo electron microscopy)
H. Saibil
10
(No Transcript)
11
Hsp70
12
Functional cycle of DnaK
Unfolded protein substrate
ATP
DnaJ
GrpE
ADPP
13
(No Transcript)
14
Substrate binding domain of DnaK
15
quality control of misfolded proteins
activity stability control of folded
proteins (Hsp70 Hsp90)
16
Hsp70-Hsp90 activation cycle
17
The Hsp70-Hsp90 chaperone machinea regulator
for signal transduction and cell cycle
plasma membrane
control of cell proliferation
c-Src
cyclin D
nucleus
Cdk4
control of G1- progression
eIF-2a- kinase
heme
cytosol
control of translation initiation
Hsp70 Hsp90
Ras
plasma membrane
activation of MAP-kinase pathway
Raf-1
stress
nucleus
activation of gene expression
HSF
steroid
nucleus
activation of gene expression
SHR
inactive
active
Mayer Bukau 1999 Curr. Biol.
18
Hsp70/Hsp90 clients
Transcription factors Steroid hormone receptors
AR, ER, GR, MR, PR Other nuclear receptors AhR,
RAR Heme activator protein (Hap1) HSF-1 Hypoxia-in
ducible factor-1a MTG8 myeloid leukemia
protein p53 Sim SV40 large T antigen Tumor
promotor-specific binding protein v-erbA
3-Phosphoinositide-dependent kinase-1 Akt Aurora
B Bcr-Abl Calmodulin-regulated eEF-2
kinase Casein kinase II Chk1 c-Mos Death domain
kinase RIP Flt3 Focal adhesion kinase GRK2 Ire1 Ik
B kinases a,b,g,e Kinase suppressor of ras
(KSR) MEK (MAP kinase kinase) MEKK1,
MEKK3 Mik1 MOK, MAK, MRK Phosphatidylinositol
4-kinase Pim-1 Polo mitotic kinase Sevenless
PTK TAK1 TBK1 trkB Wee1, Swe1
Polymerases Telomerase Hepatitis B virus reverse
transcriptase DNA-polymerase a
Kinases Src-family kinases Fps, Fes, Fgr, v-Src,
c-Src, Hck, p56lck, Yes Cycline dependent
kinases Cdc2, Cdk4, Cdk6, Cdk9 Receptor tyrosin
kinases EGFR, ErbB2, IGF-R, Insulin
receptor, PDGFR, VEGFR2 Raf family kinases
v-Raf, c-Raf, B-Raf, Gag-Mil, Ste11 eIF-2a
kinases HRI, Gcn2, Perk, PKR
19
Hsp70/Hsp90 clients
Others Aminoacyl t-RNA synthetase Apaf-1 Apoprotei
n B Atrial natriuretic peptide receptor Bid Calpon
in Centrin/centrosome Cna2 (catalytic subunit of
calcineurin) CFTR Ctf13/Skp1 component of
CBF3 Cytoskeletttal proteins actin, tubulin,
myosin eNOS, iNOS, nNOS Erythrocyte membrane
protein (Plasmodium falciparum) Fanconi anemia
group C protein G protein bg Ga0, Ga12 Guanylate
cyclase (b-subunit) HETE binding complex Histones
H1, H2A, H2B, H3, H4 Lysosomal membrane Macrophage
scavenger receptor Mdm2 MMP2 MTG8 NB-LRR
proteins RPM1 and RPS2 Neuropeptide Y
P2X7 purinergic receptor Pancreatic bile
salt-dependent lipase PB2 subunit of influenza
RNA pol. Protease-activated receptor 1
(PAR-1) Proteasome Rab-aGDI Ral-binding protein
1 Reovirus protein s1 SKP2 complexies survivin Tau
protein Thiopurine S-methyltransferase Thyroglobu
lin TLR4/MD-2 complex Vaccinia core protein 4a
http//www.picard.ch/downloads/downloads.htm Wegel
e, et al. 2004 Rev. Physiol. Biochem. Pharmacol.
20
Signal transduction pathways related to tumor
progression
Growth Receptor
Cytokines
Survival Receptor
Wnt
Death Factor
EGFR
Cytokine-R
IGF-R
Frizzoed
Grb2 SOS
Src
Fas
Cell Adhesion
PI3K
RAS
Disheveled
Bcl2/Bax
FADD
PDK1
Ral
Cdc42
JAKs
Raf
E-Cadherin
AKT
CytC
Casp 8
GSK-3b
MEK
IKK
Erk
Apaf-1/CytC/ Casp 9
APC
IkB
Elk
NFkB
b-Catenin
Stat3,5
Casp 3
b-Catenin/LEF
a-Catenin
Gene expression
Zhang Burrows 2004 J. Mol. Med.
21
Signal transduction pathways related to tumor
progression
Growth Receptor
Cytokines
Survival Receptor
Wnt
Death Factor
EGFR
Cytokine-R
IGF-R
Frizzoed
Grb2 SOS
Src
Fas
Cell Adhesion
PI3K
RAS
Disheveled
Bcl2/Bax
FADD
PDK1
Ral
Cdc42
JAKs
Raf
E-Cadherin
AKT
CytC
Casp 8
GSK-3b
MEK
IKK
Erk
Apaf-1/CytC/ Casp 9
APC
IkB
Elk
NFkB
b-Catenin
Stat3,5
Casp 3
b-Catenin/LEF
a-Catenin
Gene expression
Zhang Burrows 2004 J. Mol. Med.
22
ClpB structure
N-terminal domain (NTD)
1st ATPase (D1)
middle domain (M)
2nd ATPase (D2)
Lee et al. Cell 2003
23
ClpB Protomers form hexameric rings (in ATP)
3D model
top
side
24
Mechanism of ClpB/KJE-mediated protein
disaggregation
ClpB
Weibezahn et al., Cell 2004
25
Protein aggregates in neurodegenerative diseases
Alzheimers
Parkinsons
Plaques and tangles
Lewy bodies
PolyQ diseases
Prions
Amyloid plaques
Intranuclear inclusions
Amyotrophic lateral sclerosis
Aggregates
E. Nollen
26
Polyglutamine aggregation
Wild type lt 35 residues
Folded protein
Disease gt 35 residues
glutamine residue
other residue
Aggregate
E. Nollen
27
Caenorhabditis elegans
lives in the ground size 1mm has 959
cells has a transparent body, observable in
light microscope life span 20 days
Perfect tool - easy genetic manipulation
28
C. elegans, a model system to study Dementia
Promotor Unc-54
Qn
GFP
Protein aggregates Huntington
29
Length dependent aggregation of polyQ-YFP in C.
elegans
Unc-54
Qn
GFP
Morley et al., 2002
30
Q19-expressing animals
Q82-expressing animals
PolyQ of a length of n35 cause - protein
aggregation - drastic impaired mobility
3-4 days old C. elegans
MorleyMorimoto
31
Firefly Luciferase
Luciferase
Luciferin ATP O2 Oxoluciferin CO2
Light emission
Write a Comment
User Comments (0)
About PowerShow.com